Evidence based therapy by diagnosis: moderate to severe LVSD
| Medicine (n = 28) | Cardiology (n = 108) | Level of significance | National Heart Failure Audit standard | |
|---|---|---|---|---|
| ACEi/ARB (%) | 14 (50.0) | 95 (87.9) | <0.001 | (85.0) |
| Beta blockers (%) | 18 (64.2) | 107 (99.1) | <0.001 | (85.0) |
| Mineralocorticoid receptor anatagonists (%) | 11 (39.3) | 74 (68.5) | <0.001 | (51.0) |
| Combination (%) | 5 (17.9) | 72 (66.7) | <0.001 | (41.0) |
| Cardiac devices (%) | 1 (3.57) | 28 (25.9) | <0.001 | (39.0) |